Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
nerdculture.de is one of the many independent Mastodon servers you can use to participate in the fediverse.
Be excellent to each other, live humanism, no nazis, no hate speech. Not only for nerds, but the domain is somewhat cool. ;) No bots in general. Languages: DE, EN, FR, NL, ES, IT

Administered by:

Server stats:

1.2K
active users

nerdculture.de: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#triglyceride

0 posts0 participants0 posts today
Public
AskPippa🇨🇦

One in three #SouthAsians with #ASCVD on statins are eligible for icosapent ethyl (IPE). IPE should be considered for this high-risk population.
Story I wrote for the #MedicalPost. (Sorry, password protected for #doctors and #pharmacists).

Highlights:
A third of South Asians in Canada with known atherosclerotic #cardiovascular disease (ASCVD) and who take #statins would qualify to get additional treatment with icosapent ethyl (IPE).

This is a significant-sized population who could benefit from the additional lowering of triglycerides using IPE, according to a study presented at the recent annual meeting of the Canadian Cardiovascular Society (#CCS). This year’s CCS had 1,400 in-person delegates, over 350 online delegates and 130 sessions.

However, a major study, the REDUCE-IT trial driving the use of IPE had very few non-white participants, according to a poster abstract presented by Canadian researchers.

IPE is a highly purified preparation of #eicosapentaenoic acid (EPA), which is an omega-3 fatty acid. It is used to treat severe hypertriglyceridemia (500 mg/dL and over). It is used as an adjunct to statin therapy to reduce the risk of cardiovascular events in people whose serum #triglyceride levels are over 150 mg/dL.
#MedMastodon

canadianhealthcarenetwork.ca/o

ExploreLive feeds
About